open-angle glaucoma. Primary open-angle glaucoma
Conditions
Interventions
Intervention 1: Control group: will be received placebo daily. Intervention 2: Intervention group: will be received shabyar pills daily.
Placebo
Treatment - Drugs
Control group: will be received placebo daily
Intervention group: will be received shabyar pills daily
Sponsors
Vice Chancellor for Research (VCR) of Tabriz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 70 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria:age between 20-70 years; patients with open-angle glaucoma with IOP 11-21 mm Hg; patients with Informed consent. Exclusion criteria: patients that who have angle-closure glaucoma; Crohn's and Colitis Disease; hemorrhoids; use of systemic drugs to interfere with the IOP and pregnant women.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intraocular pressure. Timepoint: Before the intervention, one month after and two months after intervention. Method of measurement: IOP measurement with Goldmann tonometer. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects. Timepoint: One month and two months after intervention. Method of measurement: questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactEbrahim khalil Banihabib
School of Traditional Medicine,Tabriz University of Medical Sciences
Outcome results
None listed